Panaxia & Neuraxpharm Launch Medical Cannabis Extracts In Europe, More Products To Come

producer Panaxia Labs Israel Ltd. (TASE: PNAX), a subsidiary of Panaxia Global (TASE: PNAX) and Neuraxpharm, a European company that specializes in the central nervous system have launched sales of extracts under the joint Brand: Naxiva-Panaxol in Germany.

Product sales, which kicked off after successfully passing rigorous lab tests upon arrival in Germany, were approved for distribution and sales in accordance with the regulatory permit for marketing the products granted in the country, both companies confirmed Wednesday.

The companies, which teamed up earlier this year to begin marketing products, also say that they …

Full story available on Benzinga.com

More Panaxia & Neuraxpharm Launch Medical Cannabis Extracts In Europe, More Products To Come